Zimmer Biomet Holdings Retained Earnings increased by 1.6% to $11.80B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.1%, from $11.23B to $11.80B. Over 5 years (FY 2020 to FY 2025), Retained Earnings shows an upward trend with a 2.9% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase signals strong historical profitability and reinvestment, while a decrease may indicate losses or significant dividend payouts.
This represents the cumulative net income earned by the company since its inception, minus any dividends paid to shareho...
A key metric for all established companies; growth rates are compared against peers to gauge long-term success.
retained_earnings| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $10.33B | $10.43B | $10.29B | $9.50B | $9.61B | $9.74B | $9.56B | $9.74B | $9.90B | $10.01B | $10.38B | $10.51B | $10.70B | $10.90B | $11.10B | $11.23B | $11.34B | $11.52B | $11.61B | $11.80B |
| QoQ Change | — | +0.9% | -1.3% | -7.7% | +1.1% | +1.4% | -1.9% | +1.9% | +1.6% | +1.1% | +3.7% | +1.2% | +1.8% | +1.9% | +1.8% | +1.2% | +0.9% | +1.6% | +0.8% | +1.6% |
| YoY Change | — | — | — | — | -7.0% | -6.6% | -7.1% | +2.5% | +3.1% | +2.8% | +8.6% | +7.9% | +8.1% | +8.9% | +6.8% | +6.9% | +5.9% | +5.6% | +4.6% | +5.1% |